Literature DB >> 21848643

Upregulation of Ras/Raf/ERK1/2 signaling and ERK5 in the brain of autistic subjects.

K Yang1, A M Sheikh, M Malik, G Wen, H Zou, W T Brown, X Li.   

Abstract

Autism is a neurodevelopmental disorder characterized by impairments in social interaction, verbal communication and repetitive behaviors. A number of studies have shown that the Ras/Raf/ERK1/2 (extracellular signal-regulated kinase) signaling pathway plays important roles in the genesis of neural progenitors, learning and memory. Ras/Raf/ERK1/2 and ERK5 have also been shown to have death-promoting apoptotic roles in neural cells. Recent studies have shown a possible association between neural cell death and autism. In addition, two recent studies reported that a deletion of a locus on chromosome 16, which included the mitogen-activated protein kinase 3 (MAPK3) gene that encodes ERK1, is associated with autism. Most recently, our laboratory detected that Ras/Raf/ERK1/2 signaling activities were significantly enhanced in the brain of BTBR mice that model autism, as they exhibit many autism-like behaviors. We thus hypothesized that Ras/Raf/ERK1/2 signaling and ERK5 could be abnormally regulated in the brain of autistic subjects. In this study, we show that the expression of Ras protein was significantly elevated in the frontal cortex of autistic subjects. C-Raf phosphorylation was increased in the frontal cortex, while both C-Raf and A-Raf activities were enhanced in the cerebellum of autistic subjects. We also detected that both the protein expression and activities of ERK1/2 were significantly upregulated in the frontal cortex of autistic subjects, but not in the cerebellum. Furthermore, we showed that ERK5 protein expression is upregulated in both frontal cortex and cerebellum of autistic subjects. These results suggest that the upregulation of Ras/Raf/ERK1/2 signaling and ERK5 activities mainly found in the frontal cortex of autistic subjects may be critically involved in the pathogenesis of autism.
© 2011 The Authors. Genes, Brain and Behavior © 2011 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848643     DOI: 10.1111/j.1601-183X.2011.00723.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  11 in total

1.  DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylation.

Authors:  Sun Young Kim; Yong-Mahn Han; Mihee Oh; Won-Kon Kim; Kyoung-Jin Oh; Sang Chul Lee; Kwang-Hee Bae; Baek-Soo Han
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

2.  Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia.

Authors:  Caitlin Rippey; Tom Walsh; Suleyman Gulsuner; Matt Brodsky; Alex S Nord; Molly Gasperini; Sarah Pierce; Cailyn Spurrell; Bradley P Coe; Niklas Krumm; Ming K Lee; Jonathan Sebat; Jon M McClellan; Mary-Claire King
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

Review 3.  Male gender bias in autism and pediatric autoimmunity.

Authors:  Kevin G Becker
Journal:  Autism Res       Date:  2012-03-17       Impact factor: 5.216

Review 4.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

5.  D-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling.

Authors:  Jessica A Burket; Andrew D Benson; Amy H Tang; Stephen I Deutsch
Journal:  Brain Res Bull       Date:  2013-05-15       Impact factor: 4.077

6.  Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.

Authors:  Hendrik Wesseling; Paul C Guest; Chi-Ming Lee; Erik Hf Wong; Hassan Rahmoune; Sabine Bahn
Journal:  Mol Autism       Date:  2014-07-04       Impact factor: 7.509

7.  Liver X receptor-β improves autism symptoms via downregulation of β-amyloid expression in cortical neurons.

Authors:  Ji-Xiang Zhang; Jun Zhang; Ye Li
Journal:  Ital J Pediatr       Date:  2016-05-06       Impact factor: 2.638

8.  Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.

Authors:  Tori L Schaefer; Matthew H Davenport; Lindsay M Grainger; Chandler K Robinson; Anthony T Earnheart; Melinda S Stegman; Anna L Lang; Amy A Ashworth; Gemma Molinaro; Kimberly M Huber; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

9.  Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras Signaling in Costello Syndrome.

Authors:  Gemma E Rooney; Alice F Goodwin; Philippe Depeille; Amnon Sharir; Claude M Schofield; Erika Yeh; Jeroen P Roose; Ophir D Klein; Katherine A Rauen; Lauren A Weiss; Erik M Ullian
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

10.  Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action.

Authors:  Thomas A Lanz; Edward Guilmette; Mark M Gosink; James E Fischer; Lawrence W Fitzgerald; Diane T Stephenson; Mathew T Pletcher
Journal:  Mol Autism       Date:  2013-11-15       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.